Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
D002087 |
Butyrates |
Butyrates results in increased expression of NANOG protein | increases expression | 20201064
|
D018021 |
Lithium Chloride |
Lithium Chloride results in increased expression of NANOG mRNA | increases expression | 20069066
|
D018021 |
Lithium Chloride |
SFRP2 protein affects the reaction [Lithium Chloride results in increased expression of NANOG mRNA] | affects reaction|increases expression | 20069066
|
C091888 |
monoisoamyl-2,3-dimercaptosuccinate |
monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite results in decreased expression of NANOG mRNA] | decreases expression|decreases reaction | 19615344
|
C091888 |
monoisoamyl-2,3-dimercaptosuccinate |
monoisoamyl-2,3-dimercaptosuccinate results in increased expression of NANOG mRNA | increases expression | 19615344
|
D012643 |
Selenium |
Selenium results in increased expression of NANOG protein | increases expression | 18583539
|
C017947 |
sodium arsenite |
monoisoamyl-2,3-dimercaptosuccinate inhibits the reaction [sodium arsenite results in decreased expression of NANOG mRNA] | decreases expression|decreases reaction | 19615344
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of NANOG mRNA | decreases expression | 19615344
|
D018038 |
Sodium Selenite |
Sodium Selenite results in decreased expression of NANOG mRNA | decreases expression | 18175754
|
D014212 |
Tretinoin |
Tretinoin results in decreased expression of NANOG mRNA | decreases expression | 16168501 17138961
|
D014212 |
Tretinoin |
NR6A1 protein affects the reaction [Tretinoin results in decreased expression of NANOG mRNA] | affects reaction|decreases expression | 16166633
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
5.14 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
5.35 | 16712894 17306315 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.84 | 15955085 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.23 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.31 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.41 | 16456186 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.73 | 16935849 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
3.89 | 16197459 16206674 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.24 | 16873071 16443354 16166294 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.99 | 16813970 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.60 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
3.19 | 16507464 15276417 17306315 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
3.19 | 1917145 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
4.91 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
4.91 | 16096774 16051514 |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.24 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
3.17 | 19524636 20056578 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.99 | 16129372 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.60 | 16461808 |
MESH:D019457 |
Chromosome Breakage |
|
Sodium Selenite |
5.11 | 15894690 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
2.76 | 9407595 |
MESH:D003092 |
Colitis |
|
Selenium |
10.72 | 17936198 |
MESH:D003092 |
Colitis |
|
Tretinoin |
10.72 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
Butyrates |
3.11 | 15936596 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
1.83 | 9211117 16925845 9664655 17551590 14991402 10589399 9224671 8800419 9125849 9142499 |
MESH:D003920 |
Diabetes Mellitus |
|
Sodium Selenite |
4.03 | 16285004 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
4.27 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Sodium Selenite |
4.27 | 15131321 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
4.91 | 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.28 | 16569247 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
3.78 | 16938888 9664655 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
3.87 | 17994277 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
5.08 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
3.17 | 17312396 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
3.36 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.60 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
3.02 | 9664655 14991402 |
MESH:D006333 |
Heart Failure |
|
Selenium |
3.23 | 17162251 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.40 | 12676792 |
MESH:D006869 |
Hydronephrosis |
|
Lithium Chloride |
6.46 | 19797860 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.43 | 16870215 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.93 | 16778211 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
3.16 | 15346721 12646999 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
4.64 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Sodium Selenite |
3.45 | 14714311 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
4.12 | 17994277 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
4.18 | 17551590 15992940 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
2.94 | 20008137 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
4.17 | 16518626 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.89 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.98 | 16482212 16932348 19285840 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
2.11 | 17596541 19850784 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.32 | 17301526 17712046 17361223 16766008 16891316 12679006 17294898 17339181 19029980 16331271 16935935 16140955 19035177 17368321 16823087 17506722 9834237 15748426 19075265 17217047 17649720 17107899 19225113 19642359 16788101 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.50 | 9224671 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
1.81 | 18397230 16248980 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
2.45 | 15276417 16712894 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.35 | 19095001 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
1.89 | 17077188 15276417 16712894 19931552 17306315 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Sodium Selenite |
4.36 | 14737004 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
2.92 | 15318939 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.87 | 17453147 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.47 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
3.47 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.78 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.88 | 15107826 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
3.22 | 17596541 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
5.51 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
5.51 | 16946489 16594593 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
4.02 | 20056578 |
MESH:D009373 |
Neoplasms, Germ Cell and Embryonal |
marker/mechanism |
|
| 16168501 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
4.11 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
7.88 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
7.88 | 9142499 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
5.12 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
5.12 | 16936753 |
MESH:D010146 |
Pain |
|
Tretinoin |
3.13 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
2.54 | 15976015 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
5.33 | 15087411 |
MESH:D011141 |
Polyuria |
|
Lithium Chloride |
6.39 | 19692487 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.28 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
Sodium Selenite |
3.28 | 18760546 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.91 | 16636307 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
5.19 | 16723453 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
4.40 | 16116481 16283617 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
6.18 | 19524636 18572023 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
6.18 | 16467112 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
4.01 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
1.80 | 17261132 |
MESH:D013964 |
Thyroid Neoplasms |
|
Butyrates |
8.28 | 17967635 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
8.28 | 17045167 16026305 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
4.05 | 16051514 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.38 | 16040207 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
2.59 | 11723127 16712894 16452187 17306315 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
10.31 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
10.31 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
5.05 | 16752155 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.82 | 17056641 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
4.39 | 16761959 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
4.22 | 16287080 |